Optimization and scale-up of Wharton's jelly-derived mesenchymal stem cells for clinical applications

Stem Cell Research

Volumn 5, Issue 3, 2010, Pages 244-254

  Nekanti, Usha ^a   Mohanty, Lipsa ^a   Venugopal, Parvathy ^a   Balasubramanian, Sudha ^a   Totey, Satish ^b   Ta, Malancha ^c  

^a MANIPAL HOSPITAL   (India)

^b Stempeutics Research Malaysia Sdn Bhd   (Malaysia)

^c Manipal Academy of Higher Education   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; HERMES ANTIGEN; HLA DR ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CELL EXPANSION; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; TISSUE ENGINEERING; UMBILICAL CORD;

ANTIGENS, CD44; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; FIBROBLAST GROWTH FACTOR 2; HLA-DR ANTIGENS; HUMANS; IMMUNOPHENOTYPING; MESENCHYMAL STEM CELLS; UMBILICAL CORD;

EID: 77957669729     PISSN: 18735061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.scr.2010.08.005     Document Type: Article

References (46)

1. Aviles R.J., Annex B.H., Lederman R.J. Testing clinical therapeutic angiogenesis using basic fibroblast growth factor (FGF-2). Br. J. Pharmacol. 2003, 140:637-646.
2. Bartmann C., Rohde E., Schallmoser K., Pürstner P., Lanzer G., Linkesch W., Strunk D. Two steps to functional mesenchymal stromal cells for clinical application. Transfusion 2007, 47:1426-1435.
3. Bonab M.M., Alimoghaddam K., Talebian F., Ghaffari S.H., Ghavamzadeh A., Nikbin B. Aging of mesenchymal stem cell in vitro. BMC Cell Biol. 2006, 7:14.
4. Bongso A., Fong C.Y., Gauthaman K. Taking stem cells to the clinic: major challenges. J. Cell. Biochem. 2008, 105:1352-1360.
5. Can A., Karahuseyinoglu S. Concise review: human umbilical cord stroma with regard to the source of fetus-derived stem cells. Stem Cells 2007, 11:2886-2896.
6. Caplan A.I. Why are MSCs therapeutics? New data: new insight. J. Pathol. 2009, 217:318-324.
7. Caplan A.I., Dennis J.E. Mesenchymal stem cells as trophic mediators. J. Cell. Biochem. 2006, 98:1076-1084.
8. Carlin R., Davis D., Weiss M., Schultz Bruce, Deryl T. Expression of early transcription factors Oct4, Sox2 and Nanog by porcine umbilical cord (PUC) matrix cells. Reprod. Biol. Endocrinol. 2006, 4:8.
9. Colter D.C., Class R., DiGirolamo C.M., Prockop D.J. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc. Natl Acad. Sci. USA 2000, 97:3213-3218.
10. Crisan M., Yap S., Casteilla L., Chen C.W., Corselli M., Park T.S., Andriolo G., Sun B., Zheng B., Zhang L., Norotte C., Teng P.N., Traas J., Schugar R., Deasy B.M., Badylak S., Buhring H.J., Giacobino J.P., Lazzari L., Huard J., Péault B. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008, 3:301-313.
11. da Silva Meirelles L., Chagastelles P.C., Nardi N.B. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J. Cell Sci. 2006, 119:2204-2213.
12. Dahlke M.H., Hoogduijn M., Eggenhofer E., Popp F.C., Renner P., Slowik P., Rosenauer A., Piso P., Geissler E.K., Lange C., Chabannes D., Mazzanti B., Bigenzahn S., Bertolino P., Kunter U., Introna M., Rambaldi A., Capelli C., Perico N., Casiraghi F., Noris M., Gotti E., Seifert M., Saccardi R., Verspaget H.W., van Hoek B., Bartholomew A., Wekerle T., Volk H.D., Remuzzi G., Deans R., Lazarus H., Schlitt H.J., Baan C.C. Toward MSC in Solid Organ Transplantation: 2008 Position Paper of the MISOT Study Group. Transplantation 2008, 88:614-619. MISOT Study Group.
13. Friedenstein A.J., Piatetzky-Shapiro I.I., Petrakova K.V. Osteogenesis in transplants of bone marrow cells. J. Embryol. Exp. Morphol. 1966, 16:381-390.
14. Gronthos S., Graves S.E., Ohta S., Simmons P.J. The STRO-1{thorn} fraction of adult human bone marrow contains the osteogenic precursors. Blood 1994, 84:4164-4173.
15. Ito N., Saito, S., Yamada M.H., Koizuka S., Obata H., Nishikawa K., Tabata Y. A novel bFGF-GH injection therapy for two patients with severe ischemic limb pain. J. Anesth. 2008, 22:449-452.
16. Jones E.A., Kinsey S.E., English A., Jones R.A., Straszynski L., Meredith D.M., Markham A.F., Jack A., Emery P., McGonagle D. Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum. 2002, 46:3349-3360.
17. Koc O.N., Day J., Nieder M., Gerson S.L., Lazarus H.M., Krivit W. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant. 2002, 30:215-222.
18. Laham R.J., Chronos N.A., Pike M., Leimbach M.E., Udelson J.E., Pearlman J.D., Pettigrew R.I., Whitehouse M.J., Yoshizawa C., Simons M. Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I open-label dose escalation study. J. Am. Coll. Cardiol. 2000, 36:2132-2139.
19. Lakshmipathy U., Verfaillie C. Stem cell plasticity. Blood 2005, 19:29-38.
20. Le Blanc K. Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy 2003, 5:485-489.
21. Lund R.D., Wang S., Lu B., Girman S., Holmes T., Sauvé Y., Messina D.J., Harris I.R., Kihm A.J., Harmon A.M., Chin F.Y., Gosiewska A., Mistry S.K. Cells isolated from umbilical cord tissue rescue photoreceptors and visual functions in a rodent model of retinal disease. Stem Cells 2007, 25:602-611.
22. Mazzini L., Mareschi K., Ferrero I., Vassallo E., Oliveri G., Boccaletti R., Testa L., Livigni S., Fagioli F. Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis. Neurol. Res. 2006, 28:523-526.
23. Miura M., Miura Y., Padilla-Nash H.M., Molinolo A.A., Fu B., Patel V., Seo B.M., Sonoyama W., Zheng J.J., Baker C.C., Chen W., Ried T., Shi S. Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells 2006, 24:1095-1103.
24. Mueller S.M., Glowacki J. Age-related decline in the osteogenic potential of human bone marrow cells cultured in three-dimensional collagen sponges. J. Cell. Biochem. 2001, 82:583-590.
25. Nekanti U., Rao V.B., Bahirvani A.G., Jan M., Totey S., Ta M. Long-term expansion and pluripotent marker array analysis of Wharton's jelly-derived mesenchymal stem cells. Stem Cells Dev. 2010, 19:117-130.
26. Numaguchi Y., Sone T., Okumura K., Ishii M., Morita Y., Kubota R., Yokouchi K., Imai H., Harada M., Osanai H., Kondo T., Murohara T. The impact of the capability of circulating progenitor cell to differentiate on myocardial salvage in patients with primary acute myocardial infarction. Circulation 2006, 114:1114-1119.
27. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
28. Prusa A.R., Marton E., Rosner M., Bernaschek G., Hengstschläger M. Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research?. Hum. Reprod. 2003, 18:1489-1493.
29. Reinisch A., Bartmann C., Rohde E., Schallmoser K., Bjelic-Radisic V., Lanzer G., Linkesch W., Strunk D. Humanized system to propagate cord blood-derived multipotent mesenchymal stromal cells for clinical application. Regen. Med. 2007, 2:371-382.
30. Ringden O., Uzunel M., Rasmusson I., Remberger M., Sundberg B., Lonnies H., Marschall H.U., Dlugosz A., Szakos A., Hassan Z., Omazic B., Aschan J., Barkholt L., Le Blanc K. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 2006, 81:1390-1397.
31. Rodriguez R., Rubio R., Masip M., Catalina P., Nieto A., de la Cueva T., Arriero M., San Martin N., de la Cueva E., Balomenos D., Menendez P., García-Castro J. Loss of p53 induces tumorigenesis in p21-deficient mesenchymal stem cells. Neoplasia 2009, 11:397-407.
32. Samuelsson H., Ringdén O., Lönnies H., Le Blanc K. Optimizing in vitro conditions for immunomodulation and expansion of mesenchymal stromal cells. Cytotherapy 2009, 11:129-136.
33. Schwarz E.J., Alexander G.M., Prockop D.J., Azizi S.A. Multipotential marrow stromal cells transduced to produce L-DOPA: engraftment in a rat model of Parkinson disease. Hum. Gene Ther. 1999, 10:2539-2549.
34. Schwarz E.J., Reger R.L., Alexander G.M., Class R., Azizi S.A., Prockop D.J. Rat marrow stromal cells rapidly transduced with a self-inactivating retrovirus synthesize L-DOPA in vitro. Gene Ther. 2001, 8:1214-1223.
35. Secco M., Zucconi E., Vieira N.M., Fogaça L.L., Cerqueira A., Carvalho M.D., Jazedje T., Okamoto O.K., Muotri A.R., Zatz M. Multipotent stem cells from umbilical cord: cord is richer than blood!. Stem Cells 2008, 26:146-150.
36. Sekiya I., Larson B.L., Smith J.R., Pochampally R., Cui J.G., Prockop D.J. Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 2002, 20:530-541.
37. Sotiropoulou P.A., Perez S.A., Salagianni M., Baxevanis C.N., Papamichail M. Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells 2006, 24:462-471.
38. Stenderup K., Justesen J., Clausen C., Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 2003, 33:919-926.
39. Suzuki N., Rohdewohld H., Neuman T., Gruss P., Schöler H.R. Oct-6: a pou transcription factor expressed in embryonal stem cells and in the developing brain. EMBO J. 1990, 9:3723-3732.
40. Tarte K., Gaillard J., Lataillade J.J., Fouillard L., Becker M., Mossafa H., Tchirkov A., Rouard H., Henry C., Splingard M., Dulong J., Monnier D., Gourmelon P., Gorin N.C., Sensebé L. Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation. Blood 2010, 115:1549-1553.
41. Tonti G.A., Mannello F. From bone marrow to therapeutic applications: different behaviour and genetic/epigenetic stability during mesenchymal stem cell expansion in autologous and foetal bovine sera?. Int. J. Dev. Biol. 2008, 52:1023-1032.
42. Troyer D.L., Weiss Wharton's M.L. jelly-derived cells are a primitive stromal cell population. Stem Cells 2008, 26:591-599.
43. Tse W.T., Pendleton J.D., Beyer W.M., Egalka M.C., Guinan E.C. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003, 75:389-397.
44. Tsutsumi S., Shimazu A., Miyazaki K., Pan H., Koike C., Yoshida E., Takagishi K., Kato Y. Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem. Biophys. Res. Commun. 2001, 288:413-419.
45. Van den Bos C., Mosca J.D., Winkles J., Kerrigan L., Burgess W.H., Marshak D.R. Human mesenchymal stem cells respond to fibroblast growth factors. Hum. Cell 1997, 10:45-50.
46. Wang Y., Huso D.L., Harrington J., Kellner J., Jeong D.K., Turney J., McNiece I.K. Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture. Cytotherapy 2005, 7:509-519.